Active vs. Passive Investing: Why the Math Favors Passive Every Time

There are two main ways fund companies approach investing: active and passive.

Active managers hire expensive research teams to pick whether Coke or Pepsi will do better. The goal is to "beat the market."

Passive managers just buy Coke and Pepsi. Lower overhead means lower costs for you. Simple as that.

The overwhelming majority of academic evidence supports passive investing over active. Here's just one example of why.

The Arithmetic of Active Management

We nerds at ER Doc Finance love math, and math shows that passive management wins.

The total market return is the sum of the returns achieved by all investors, passive and active combined:

Total Return = Passive Return + Active Return

Now assume 30% of investors are passive and 70% are active:

Total Return = (30% × Passive Return) + (70% × Active Return)

Now assume the total return is 10%. Passive investors are simply buying the entire market, so their return is also 10% before costs.

10% = (30% × 10%) + (70% × Active Return)

It follows that the active investors' return must also be 10% before costs.

10% = (30% × 10%) + (70% × 10%)

So passive and active investors both earned 10%, right? Not so fast. That's before costs.

Assume an average cost of 0.2% for a passively managed fund and 1.0% for an actively managed fund. After costs, Jane Passive earned 9.8% and Joe Active earned 9.0%.

Even if an active manager keeps pace with the market before fees, costs alone put them behind. So why not just find an active manager who's good enough to overcome their higher fees? Someone who genuinely can "beat the market?"

Identifying Above-Average Managers Is Hard

To win with active management, you need a manager who outperforms by enough to offset their higher fees. That's very difficult to find.

[CHECK: The original post cited SPIVA data through December 31, 2020, showing only 25% of mutual fund managers beat their benchmark after fees. The SPIVA U.S. Scorecard Year-End 2024 tells an even stronger story — over the 15-year period ending December 2024, no U.S. equity category had a majority of active managers outperforming. Consider updating to this more current data before publishing.]

Over the 5-year period ending December 31, 2025, only 11.04% of all Large-Cap funds outperformed the S&P 500. (source: SPIVA® U.S. Scorecard, Year-End 2025).

OK, but what if you just invested with the managers who outperformed in the past and let them keep outperforming? That strategy is likely to fail too. The SPIVA Persistence Scorecard consistently shows that active outperformance doesn't stick: among top-quartile large-cap funds from 2020, not a single one remained in the top quartile four years later (source: SPIVA® U.S. Persistence Scorecard, Year-End 2024).

Those aren't good odds.

What Does This Mean for Me?

If you're an emergency physician committed to evidence-based investing, a passive approach makes sense. That means choosing low-cost, index-like funds and not trying to "beat the market."

Ready to put this into practice? If you're an ER physician or high-income professional looking for straightforward, evidence-based financial guidance, we'd love to connect. Schedule a free intro call with Yahara Wealth Management — no pressure, no sales pitch, just a conversation.

This article is for educational purposes only and does not constitute personalized investment advice. Past performance is not indicative of future results. Please consult a qualified financial advisor before making investment decisions.